We're not for everyone.
We’re for those who believe uniting evidence and access improves patient outcomes.
We connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation.
Expertise that unites real-world evidence and patient access to improve outcomes.
UBC brings together seasoned professionals specializing in specialty therapies across risk management, evidence development, and patient access. Providing collaborative, expert-driven solutions tailored to your program, we are driven by a commitment to overcoming the barriers between your therapy and the patients that need it most. We leverage unrivaled expertise, real-world data and the latest technologies to provide the insights you need to mitigate risk, demonstrate long-term product value, ensure access, and support better patient outcomes.
Explore Biopharma Services
Purpose-built solutions to deliver the evidence required to inform stakeholder decision making.
Evidence Development
Expert-led evidence generation solutions to guide you through every step of program design and delivery, from modernized study designs to late-stage research. We develop real-world evidence strategies that align with the expectations of patients, providers, regulators, and payers — and help you navigate the complexities of approval, commercialization, and delivery of long-term outcomes.
Safety & Risk Management
Comprehensive, tailored drug safety and global risk management solutions that are sophisticated, tech-enabled, and regulatory compliant. Our decades of experience drive strategies to address the benefit/risk profile of specialty therapies, optimize pharmacovigilance, and ensure every decision is informed.
Patient Access
A targeted approach that integrates high-tech and high-touch care for exceptional patient access, affordability, and adherence solutions. Purpose-built to fit unique patient health journeys, our patient access support addresses payer and insurance hurdles while building a seamless, scalable experience and enhancing patient outcomes.
Insights
Linking real-world data with commercial patient access programs: A strategy for enhanced insights into factors that impact patient access and adherence to therapy
UBC’s approach to real-world data tokenization and linkage enhances study results with longitudinal observation of various participant health outcomes during the pre-and post-trial period.
News
UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025
UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.
Events
DIA Global Annual Meeting 2025
Join UBC’s evidence development, safety, and risk management experts in D.C. at the ultimate hub for pharma leaders.
